期刊文献+

PI3K/Akt信号通路在RANKL诱导的MCF-7乳腺癌细胞迁移中的作用 被引量:1

PI3K/AKT was involved in RANKL-induced breast cancer cell MCF-7 migration
下载PDF
导出
摘要 目的:核因子-κB受体活化因子配体(RANKL)能促进表达RANK的上皮癌细胞迁移至骨,与乳腺癌骨转移密切相关。本文探讨磷脂酰肌醇-3-激酶/丝苏氨酸蛋白激酶(phosphoinositide3-kinase/serine/threonine protein kinase PI3K/Akt)信号通路在RANKL诱导的乳腺癌MCF-7细胞迁移中的作用。方法:流式细胞仪检测MCF-7细胞表面RANK蛋白的表达;Transwell法测定RANKL刺激后MCF-7细胞迁移能力的改变;Western-blot检测MCF-7细胞RANKL刺激后p-Akt及Akt的表达。SPSS 16.0软件分析实验数据。结果:MCF-7细胞表达RANK蛋白,RANKL诱导MCF-7细胞迁移能力显著增强,RANKL的圈套受体OPG可阻断RANKL诱导的细胞迁移。RANKL刺激后MCF-7细胞p-Akt表达在1、5分钟时一过性升高,PI3K抑制剂LY294002显著抑制RANKL诱导的细胞迁移。结论:PI3K/Akt信号通路参与RANKL诱导的乳腺癌细胞系MCF-7迁移。 Objective:Receptor activator for nuclear factor kappa B ligand / receptor activator for nuclear factor kappa B(RANKL/RANK)pathway is critical for RANK-expressing cancer cells to home to bones.There is few report about the role of phosphoinositide 3-kinase/serine/threonine protein kinase(PI3K/Akt)pathway in regulation of cancer cells migration by RANKL.The present study aimed to evaluate the role of PI3K/Akt in RANKL-induced breast cancer MCF-7 cells migration.Methods: Flow cytomety was used to detect the surface RANK expression in human breast cancer cell lines MCF-7.Transwell was used to test the migration of MCF-7,Western blotting test the expression of phospho-Akt and Akt.Results: RANK was expressed in human breast cancer cell line MCF-7,and RANKL increased the migration of breast cancer cells significantly.The decoy receptor of RANKL,OPG,blocked RANKL-induced breast cancer cells migration.The Expression of p-Akt increased from 1 to 5 minutes after RANKL stimulating,LY294002,PI3K/Akt inhibitor significantly inhibited RANKL-induced breast cancer cells migration.Conclusion: PI3K/Akt was involved in RANKL-induced breast cancer MCF-7 cells migration.
出处 《现代肿瘤医学》 CAS 2012年第2期224-227,共4页 Journal of Modern Oncology
基金 国家青年科学基金资助项目(编号:30700807) 辽宁省教育厅科研基金资助项目(编号:2010225032) 辽宁省重点实验室项目(编号:2008S246)
  • 相关文献

参考文献13

  • 1Nakagawa N,Kinosaki M,Yamaguchi K,et al.RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis[J].Biochem Biophys Res Commun,1998,253(2):395-400.
  • 2Jones DH,Nakashima T,Sanchez OH,et al.Regulation of cancer cell migration and bone metastasis by RANKL[J].Nature,2006,440(7084):692-696.
  • 3Chen L-M,Kuo C-H,Lai T-Y,et al.RANKL increases migration of human lung cancer cells through intercellular adhesion molecule-1 up-regulation[J].J Cell Biochem,2011,12(3):933-941.
  • 4Armstrong AP,Miller RE,Jones JC,et al.RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes[J].Prostate,2008,68(1):92-104.
  • 5Hernandez-Aya LF,Gonzalez-Angulo AM.Targeting the phosphatidylinositol 3-kinase signaling pathway in breast cancer[J].Oncologist,2011,16(4):404-414.
  • 6Sabbota AL,Kim HRC,Zhe X,et al.Shedding of RANKL by tumor-associated MT1-MMP activates src-dependent prostate cancer cell migration[J].Cancer Res,2010,70(13):5558-5566.
  • 7Fizazi K,Carducci M,Smith M,et al.Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer:a randomised,double-blind study[J].Lancet,2011,377(9768):813-822.
  • 8Jakob C,Goerke A,Terpos E,et al.Serum levels of total-RANKL in multiple myeloma[J].Clin Lymphoma Myeloma,2009,9(6):430-435.
  • 9Onishi T,Hayashi N,Theriault RL,et al.Future directions of bone-targeted therapy for metastatic breast cancer[J].Nat Rev Clin Oncol,2010,7(11):641-651.
  • 10Santini D,Perrone G,Roato I,et al.Expression pattern of receptor activator of NFκB(RANK)in a series of primary solid tumors and related bone metastases[J].J Cell Physiol,2011,226(3):780-784.

同被引文献20

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部